Agoracom Blog Home

Archive for the ‘All Recent Posts’ Category

Datametrex AI $DM.ca $DTMXF Announces Release of Nexalogy “SMART” Technology $PFM.ca $VQS.ca $SPOT.ca $ADK.ca

Posted by AGORACOM-JC at 7:28 AM on Wednesday, December 16th, 2020
  • Announced the release of Nexalogy SMART – Social Media Automated Reporting Technology
  • As previously announced, Nexalogy’s SMART is an advanced proprietary AI technology
  • SMART minimizes human involvement in data analysis and reporting.
  • It significantly decreases the time required for integration and interpretation of large data sets and report production
  • Now fully available

Toronto, Ontario–(December 16, 2020) –  Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) (the “Company” or “Datametrex”) is pleased to announce the release of Nexalogy SMART – Social Media Automated Reporting Technology.

As previously announced, Nexalogy’s SMART is an advanced proprietary AI technology. SMART minimizes human involvement in data analysis and reporting. It significantly decreases the time required for integration and interpretation of large data sets and report production. It is now fully available.

SMART takes NexaIntelligence to the next level with AI-powered automated reporting technology. It quickly generates reports with all of NexaIntelligence’s visualizations, augmenting the reporting capacity of analysts. Human resources are a scarce commodity. SMART integrates larger sets of data into smaller, more manageable reports, thus significantly reducing the number of resource hours required to identify insights.

Our AI pre-reads text, selects verbatims, and summarizes themes quickly, reliably, and with precision. The AI technology creates powerful reports based on our algorithms and automatically selects the most important original posts to include, in minutes rather than hours. Analysts can specify filters on the data to get automatic reports on subsets of the data focusing on specific times, entities, social media users, or topics. This means social media trends can be understood faster and with less difficulty, keeping companies ahead of the curve.

SMART’s scheduling functionality allows companies to structure reporting to match regular schedules as needed or in response to triggering events in the data itself. AI-written reports are emailed to analysts inconvenient and easy to read file formats, such as MSWORD or PDF. Raw JSON outputs from Nexalogy’s API are also available for use in white labelled products.

AI reporting on social media and other forms of unstructured text is increasingly important and relevant in the information landscape. The need for strategic reporting of data from these platforms in both the public and private sectors is growing at a rapid pace. The ability to analyze and monetize social media discussions, as well as unstructured text from owned sources, are key strengths of SMART. Breaking through information bottlenecks and resource limitations, SMART can take big data discovery and exploration to a new level of actionable insights.

“Our AI helps you unlock the power of discovery, converting unknown unknowns into known knowns, activating the hidden potential currently lost in big data. With social media and unstructured text being a key facet of how businesses and consumers connect during the pandemic, we feel SMART is uniquely positioned to assist clients in unlocking potential in current verticals and exploring the potential of new verticals; for security, we help you discover unknown problems so you can squash them before they become big problems. For growth, we help you discover and unlock hidden potential,” said Marshall Gunter, CEO of Datametrex AI Limited.

To see more and download example reports, click here: https://nexalogy.com/product/

About Datametrex

Datametrex AI Limited is a technology-focused company with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, the Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.

For further information, please contact:
Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

###

MEDIA: The doctor will stream you now: How Binovi $VISN.ca $BNVIF is leading the charge in virtual vision therapy $EYPT $KALA $PTON $WELL.ca $DOC.ca $DOCRF

Posted by AGORACOM-JC at 4:27 PM on Tuesday, December 15th, 2020
  • The pandemic has created a new consumer expectation for virtual services
  • Tech company Binovi gives optometry patients a new alternative
  • With Binovi Connect, the company has created a seamless network for vision care professionals to work together

With 2020 becoming the year of the homebody, we’ve all had to drastically reduce our trips out of the house. While it’s been hard on everyone, we can consider ourselves lucky that there were already numerous resources to ease the transition into sheltering in place.

It’s no secret that companies bridging the distance between services like food delivery apps, and 24-hour product distribution have been the trend for a while now. Still, with communities shutting down, many newer services crossed the line from following the trend into being embedded into daily life.

While things like Zoom conferences and virtual personal training have been an infrequent occurrence pre-pandemic, consumers have realized that they’re now mainstream and accepted options to save time and social distance.

Office groups are even doing video-streamed murder mystery parties in place of their traditional in-person Christmas gatherings. It’s a new language of behaviour that we’re becoming fluent in as we continue to adapt to how COVID has changed our lives.

Even as restrictions lift and the curve eventually flattens, it’s hard to see a future without these new tools at consumers’ disposal. For instance, who would want to go back to sitting in a crowded waiting room, when you could simply have an online conference with your doctor? This Binovi Platform allows users to browse from a list of Binovi Providers, schedule appointments, conduct screening, and more.

It’s a shift that has already changed the healthcare industry. Specialist professionals can now maximize their patient schedule and keep appointments as socially distanced as possible. While it’s a handy change of pace, there has already been an opportunity to create a more accessible network to maximize efficiency and accuracy for both doctors and patients.


“Once a training regimen is established, along with a schedule for check-ins and evaluations, users can conduct their own training sessions.”

— Adam Cegielski, CEO, Binovi Technologies Corp.


Binovi offers the patient management resource that medical professionals have been waiting for

With one in four people worldwide living with issues related to vision that go beyond visual acuity, it’s time to address this gap and come up with an effective and efficient way for specialists to meet with patients during the pandemic and beyond.

Enter Binovi Technologies (TSXV: VISN | OTCQB: BNVIF), a best-in-class neuro-visual performance platform designed to test, analyze, track, and report on individual cognitive performance.

Established to enhance how optometrists work with their patients and bring treatment into the 21st century, Binovi is supported by recognized optometry leaders worldwide.

This connection to vision therapists, occupational therapists, and physical therapists has led the company towards innovative testing methods that patients can do remotely. While in the presence of a professional, patients produce quantifiable data that Binovi can analyze, consult with other professionals about, and recommend the next steps for treatment.

Binovi’s experience with facilitating a channel between professionals and patients has led to the company’s latest telehealth innovation, Binovi Connect, which is a web-based video conferencing solution that connects consumers to vision care professionals focused on concussions, reading skills, and athletic enhancement.

The new application not only gives a straightforward service to both parties, but it provides a network for professionals to consult and collaborate with each other about specific patient treatments. It’s a streamlining of service that gives clarity and peace of mind to anyone who has felt like they might not have grasped everything their doctor has just said.

Patients can easily choose from specialists who best meet their needs, establish a routine with their selected one, and monitor in real-time the results they’ve made. On the other side of things, doctors can see notes from other professionals and collaborate on multiple fronts to create multi-tiered treatment tactics for shared patients.

It’s a program that has countless applications in the healthcare world, but for the moment, Binovi is remaining focused on vision-based therapy. With 800 clinics across the globe already using Binovi’s systems, their market share of the $74 billion a year Visioncare industry will only grow.
 

To do that, the company emphasizes the program’s ease of use and a clear value proposition. Binovi Connect is incredibly user-friendly, and patients are given everything they need to create progress.

“Once a training regimen is established, along with a schedule for check-ins and evaluations, users can conduct their own training sessions,” says Cegielski.

“This is happening while still under the watchful eye of their healthcare professionals who can monitor the results with session data stored in the cloud.”

Since the launch of this platform, the 800 organizations have created nearly 31,000 users, together completing more than 400,000 active sessions centered around the Binovi Library list of activities.

Niche treatments for niche ailments

When it comes to niche treatments, Binovi offers patients the materials they need as recommended by each doctor for treatment. This could be equipment for equilibrium building exercises or the means to conduct a supervised vision test.

Binovi Coach encourages and empowers patients to confidently complete their prescribed home therapy with clarity and guidance.

The insights from these sessional treatments are then boosted by the program’s AI. Cloud-based session data is effectively merged with data from the clinicians’ past findings, then offered to each patient’s current therapist. This allows each session to produce real-time suggestions, and present immediate resources to each therapist.

It’s a groundbreaking new approach to treatment, that has produced startling results for patients suffering from concussions, binocular vision dysfunction, amblyopia, and countless other afflictions. With Binovi, patients can actively improve dynamic visual acuity, visual reaction time, depth perception, and hand-eye/body-eye coordination.

The framework is already in place for patients to receive the specialized care they need regardless of geography or time zone. Now, it’s just a matter of time before consumer standards for virtual appointments and personal care reach a tipping point. Determining whether someone needs vision therapy, or could benefit from vision training, can start early.

When that happens, Binovi is ready to serve.

So, what’s next for the platform?

  • Migrating offline sessions to Binovi Connect
  • Inclusion of a broader class of providers
  • Support for more languages
  • Release of SDK for integration with other platforms
  • Anonymized data access for research
  • Expecting to launch a Beta version of the app by fiscal Q1 2021

“We are excited to continue to build out a robust telehealth platform as we continue our mission to be the leader in neuro-vision performance technology space.”

Why should investors take note of Binovi?

Binovi’s future innovation opportunities are largely driven by identifying high-value client needs and evaluating each unique opportunity to develop new products and services in the areas of neurotechnology and vision training to support unlocking human performance.

The company’s future innovation pipeline looks like this:

  • Expanding its capabilities within the education sector
  • Partnering with elite athletes, professional sports as well as esports teams
  • Standardizing data collection in the field to create optimized training regimens based on unique profiles, peer groups and custom goals
  • Working with military and law enforcement
  • Treating the aging population and improving performance for those affected by the impact of brain-related diseases or natural aging

Binovi’s innovation milestones from first acquiring Wayne Engineering in 2015 and its educational IP to commercializing its Binovi Connect Platform.

Additionally, the acquisition and integration of the VIMA Rev Strobe Lenses under the Binovi umbrella has provided Binovi with an additional toolset to expand its offering. Developed by Nike’s former Global Director of Vision Science and his team of sport science experts, the VIMA Rev Strobe Lenses are an integrated strobe training system that stimulates neuro-cognition through vision training.

VIMA’s technology is being integrated into Binovi’s product platform, with several orders already fulfilled. Current VIMA Rev strobe users include the NHL’s Colorado Avalanche, the NBA’s Golden State Warriors, Chicago Bulls and the Milwaukee Bucks.

Binovi has had a tremendous year so far, and they’re not done yet.

To learn more about the company, visit their website here.

Follow Binovi Technologies on social media:

Facebook
Twitter
LinkedIn
Instagram

Source: https://www.bnnbloomberg.ca/the-doctor-will-stream-you-now-how-binovi-is-leading-the-charge-in-virtual-vision-therapy-1.1536215

AGORACOM Welcomes Valeo Pharma $VPH.ca $VPHIF With 7 Products To Be Launched In 2021 / 2022 ($45M. Estimated Peak Sales / Year) $HLS.ca $MDP.ca $GUD.ca $RX.ca

Posted by AGORACOM-JC at 3:31 PM on Tuesday, December 15th, 2020

(VPH: CSE) (VPHIF: OTCQB) (VP2: FSE)

www.valeopharma.com

Why Valeo Pharma?

  • Commercial stage revenue generating Canadian pharmaceutical company
  • Approaching EBITDA positive in coming months
  • 9 products currently marketed ($40M. estimated peak sales / year)
  • 7 additional products in pipeline ($45M. estimated peak sales / year)
  • In-license business model, no development or clinical risk
  • $1.5M in quarterly revenue ending July 31, 2020
  • $5.26M in revenue for 9 months ending July 31, 2020

What Exactly Does Valeo Pharma Do?

  • Acquires Canadian rights to commercial stage, innovative and proprietary drugs
  • Commercializes innovative prescription products in Canada
  • Focused on Neurodegenerative Diseases,  Oncology and Hospital Specialty Products
  • Internally manages portfolio through all stages of commercialization

Commercial Portfolio

VPH-Commercial-Portfolio

Here’s just a few products already approved:

BRAND: REDESCA® (BIOSIMILAR)

Launch: Q1-2021

Status: Approved by Health Canada December 2020

Indication: Injectable blood thinner

Market size:  $200M

Peak sales estimate $30 – $40M, sales margin 55 – 60% https://www.youtube.com/embed/XNn29Cx2ToY

BRAND: HESPERCOTM

Launch: Launched in Q4 -2020

Status: Approved by Health Canada

What is it: Anti-Oxidant – Immune system support

How’s it sold: Retail, Online (www.hesperco.com, www.amazon.ca)

Market Size: $500M

hesperco

BRAND: ONSTRYV®

Launch: Q3 2019

Status: Received positive recommendation for public reimbursement in Quebec

Use: Parkinson’s disease, 1st treatment launched in Canada since 2006

Patient base: 100,000 in Canada 2nd chronic neurodegenerative disorder after Alzheimer

Market Size: $20M

%Peak sales estimate $8M, sales margin 65-70 %

Pipeline

Pipeline

The Valeo Model

Company Forecast

  • All portfolio & pipeline products to be on the market by end 2022
  • Solid pipeline composed of “licensed” products
  • Peak Sales reached 2-4 years after market launch
  • From 1 product on the market to 12 in 4 years and more to come
  • Forecast excludes any new product licensing

Hub On AGORACOM / Corporate Profile

AGORACOM Small Cap 60: $KABN.ca A #Fintech Platform Focused On Verifying, Managing & Monetizing Online Identity $MOS.ca $MOGO.ca $CTZ.ca

Posted by AGORACOM-JC at 1:09 PM on Tuesday, December 15th, 2020
kabn-square-new

GENERALLY KABN Turns The Problem Of Data Privacy Into A Profit For Individuals, While Providing Big Businesses With New & Compliant Business Models.

SPECIFICALLY KABN Specializes In

  • Continuous Online Identity Verification
  • Personal Identity Management
  • Personal Data Monetization.

NEW DIGITAL PRIVACY LAWS OVER THE LAST 2 YEARS ARE DRIVING CUSTOMERS TO KABN FOR THE FOLLOWING REASONS:

  • Your Online Privacy & Data Protection Is More Important Now Than Ever
  • Facebook Data Privacy Scandal Lead To The Implementation of GDPR (General Data Protection Regulation
  • GDPR Is Essentially EU Law On Digital Privacy That Strongly Regulates The Transfer Of Personal Data.
  • The Primary Purpose Of GDPR Is To Give Individuals Control Over Their Personal Data By Regulating All International Businesses That Handle Our Data
  • GDPR Became Effective May 25, 2018
  •  GDPR Was Followed By The California Consumer Privacy Act of 2018 (CCPA)
  • The CCPA Became Effective January 1, 2020.
  • Both Will Have A Significant Impact On The Way These Industries Collect and Capitalize On Personal Data
    • Social Media               (Facebook, Twitter, etc.)
    • E-commerce                (Amazon, Ali Baba, etc.)
    • Digital Payments         (PayPal, AliPay, etc.)
    • Cloud Computing       (AWS, Azure, etc.)
    • iGaming / Gambling    (Bet365, Tencent, Epic Games, etc.)

Hub On AGORACOM / Corporate Profile

CLIENT FEATURE: Innocan Pharma $INNO.ca Developing The Pharmaceutical Guided Missile To Defeat Coronavirus Lung Infections $CGC.ca TLRY $VFF.ca $APHA $OVAT.ca $KHRN.ca

Posted by AGORACOM-JC at 11:38 AM on Tuesday, December 15th, 2020
Innocan-Blog

Innocan Pharma Corporation (INNO: CSE) (IP4:FSE) is developing the pharmaceutical guided missile to defeat coronavirus lung infections. The company specializes in the development of new drug platforms which combine unique properties of Cannabinoids. 

3 Fully Operating Divisions For Investor Diversification

Innocan has 3 fully operating divisions to address the market for Cannabis products.  As a Cannabis investor, why limit yourself to a Company with just one specialty, when Innocan offers you exposure to both the exploding world of cannabis pharma, as well as, a portfolio of patent-pending and launch ready consumer health products.

PHARMACEUTICAL – THE GUIDED MISSILE – Revolutionary technology targeting lungs infected with coronavirus or other viral infections.

CONSUMER RETAIL – DERMA COSMETICS – A premium derma cosmetics brand, manufacturing has commenced with distribution agreements in place.

OVER THE COUNTER (OTC) PRODUCTS FOR PAIN RELIEF – patent-pending CBD pain relief brand received FDA technical validation.

Global Manufacturing / Distribution Agreements

  • Endless Sky Inc. a Canadian large scale Cannabis extractor (Manufacturing and Distribution – Canada)
  • Swiss CBD provider Cloud 9 Switzerland LLC (Distribution – Italy and Switzerland)
  • Active Therapeutics Ltd of Lancashire, United Kingdom (Distribution – UK and Ireland markets)
  • iAmHealth Distribution UG (Distribution – Germany)

Completed Trademark Registration in the EU, UK and Switzerland

  • Completion of the registration of its trademarks: Innocan Pharma, Relief & Go and SHIR in the EU, UK and Switzerland.
  • These trademarks represent Innocan’s OTC and derma cosmetic brand products that were recently launched in the German and UK markets.

Superior Management Team

In the small cap world, the jockey(s) that drive the horse are just as important as the horse itself.  The InnoCan Leadership Group Is Incomparable In The Small Cap World, Comprised Of Leading Israeli Pharmaceutical Executives including:

  • Executive Chairman (Ron Mayron) was the CEO Of Teva Israel, one of the largest generic pharmaceutical companies in the world
  • Co-Founder & VP Business Development (Yoram Drucker) was the Founder of 2 NASDAQ Companies (Pluristem & Brainstorm)
  • Chief Technology Officer (Nir Avram) is a former member of the pharma innovation team at Perrigo, producer of OTC consumer goods and specialty pharma.
  • Chief Executive Officer (Iris Bincovich) has a proven track record in opening global markets, having managed hundreds of successful transactions in OTC, cosmetics and dermatology.

Together they have built one of the most formidable teams in the small cap cannabis world

Hub On AGORACOM / Corporate Profile

Red Light Holland $TRIP.ca Commences Growing 1,000,000 Grams of Magic Truffles $SHRM.ca $RVV.ca $MMED $PLNT.ca $HALO.ca $PSYC.ca

Posted by AGORACOM at 9:25 AM on Tuesday, December 15th, 2020
https://i.ibb.co/ZdKv64V/Red-Light-Holland-Square.jpg

Toronto, Ontario–(Newsfile Corp. – December 15, 2020) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF) (“Red Light Holland“) is pleased to announce that is has commenced growing its second crop of approximately 1,000,000 (1 Million) grams of magic truffles consisting of three different strains, including Psilocybe Mexicana, Psilocybe Galindoi, and Psilocybe Tampanensis.

“Red Light Holland is ecstatic to announce that we have started to grow our second batch of magic truffles, expected to be 10X the original batch’s size totalling an expected 1,000,000 (1 Million) grams of Magic Truffles. We are proud as a company, in the Psychedelic sector to actually produce product now, as opposed to making mere projections about the future. We believe in providing responsible adult access now, through education and information and we are happy to be moving so quickly and efficiently,” said Todd Shapiro, Chief Executive Officer and Director of Red Light Holland. “We are almost done harvesting our expected first batch, which has been pre-sold, and we are again, excited for this future growth.”

“This is another great day for the Company. We have perfected the harvest process right through to packaging and we are excited to be growing this very large amount of Truffles,” added Hans Derix, President of Red Light Holland (who resides in Horst). “Red Light Holland’s growth operation, including sourcing of truffle’s genetics and working with substrates in a proven and perfect growing environment, including working with the proper equipment to complete the growth process from harvest right through to packaging and distribution is something we are truly proud of.”

Red Light Holland’s growth operation, which is approximately 3,000 square feet custom built, indoor growing, production and distribution facility is in Horst, The Netherlands. The expected batch of 1,000,000 grams of Magic truffles, including Psilocybe Mexicana, Psilocybe Galindoi, and Psilocybe Tampanensis is expected to be available in the Netherlands in mid 2021.

About Red Light Holland Corp.

Red Light Holland is an Ontario-based corporation engaged in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal market within the Netherlands, in accordance with the highest standards, in compliance with all applicable laws.

For additional information on Red Light Holland:

Todd Shapiro
Chief Executive Officer & Director
Tel: 647-204-7129
Email: [email protected]
Website: https://redlighttruffles.com/

Toronto, Ontario–(Newsfile Corp. – December 15, 2020) – Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF) (“Red Light Holland“) is pleased to announce that is has commenced growing its second crop of approximately 1,000,000 (1 Million) grams of magic truffles consisting of three different strains, including Psilocybe Mexicana, Psilocybe Galindoi, and Psilocybe Tampanensis.

“Red Light Holland is ecstatic to announce that we have started to grow our second batch of magic truffles, expected to be 10X the original batch’s size totalling an expected 1,000,000 (1 Million) grams of Magic Truffles. We are proud as a company, in the Psychedelic sector to actually produce product now, as opposed to making mere projections about the future. We believe in providing responsible adult access now, through education and information and we are happy to be moving so quickly and efficiently,” said Todd Shapiro, Chief Executive Officer and Director of Red Light Holland. “We are almost done harvesting our expected first batch, which has been pre-sold, and we are again, excited for this future growth.”

“This is another great day for the Company. We have perfected the harvest process right through to packaging and we are excited to be growing this very large amount of Truffles,” added Hans Derix, President of Red Light Holland (who resides in Horst). “Red Light Holland’s growth operation, including sourcing of truffle’s genetics and working with substrates in a proven and perfect growing environment, including working with the proper equipment to complete the growth process from harvest right through to packaging and distribution is something we are truly proud of.”

Red Light Holland’s growth operation, which is approximately 3,000 square feet custom built, indoor growing, production and distribution facility is in Horst, The Netherlands. The expected batch of 1,000,000 grams of Magic truffles, including Psilocybe Mexicana, Psilocybe Galindoi, and Psilocybe Tampanensis is expected to be available in the Netherlands in mid 2021.

About Red Light Holland Corp.

Red Light Holland is an Ontario-based corporation engaged in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal market within the Netherlands, in accordance with the highest standards, in compliance with all applicable laws.

For additional information on Red Light Holland:

Todd Shapiro
Chief Executive Officer & Director
Tel: 647-204-7129
Email: [email protected]
Website: https://redlighttruffles.com/

Loop Insights $MTRX.ca $RACMF Announces Appointment of New CFO , Mark Lotz $AT.ca $QTRH.ca $SNSR $BSQR $PTS.ca

Posted by AGORACOM-JC at 9:44 PM on Monday, December 14th, 2020
https://miro.medium.com/max/3150/1*f9msDHyceA_TbRM30jQhsw.png
  • Announced the appointment of Mark Lotz as Chief Financial Officer effective December 11, 2020.
  • Mr. Lotz holds a Bachelor’s degree in Business Administration with a joint major in Economics.
  • He is a Chartered Professional Accountant with 26 years of post-qualification experience, and has extensive in the capital markets across a broad cross-section of industries including SaaS, manufacturing, mining, technology and financial services.

VANCOUVER, British Columbia, Dec. 14, 2020 — Loop Insights Inc. (MTRX:TSXV) (RACMF:OTCQB) (the “Company” or “Loop”), a provider of contactless solutions and artificial intelligence (“AI”) to drive real-time insights, enhanced customer engagement, and automated venue tracing to the brick-and-mortar space, announces the appointment of Mark Lotz as Chief Financial Officer effective December 11, 2020.

Mr. Lotz holds a Bachelor’s degree in Business Administration with a joint major in Economics. He is a Chartered Professional Accountant with 26 years of post-qualification experience, and has extensive in the capital markets across a broad cross-section of industries including SaaS, manufacturing, mining, technology and financial services. Mr. Lotz has held CFO and other senior financial positions with several well-known mining and exploration companies. He has also served as a senior executive officer in the securities brokerage industry. Prior to that, he served as a securities regulator, following his tenure at Coopers & Lybrand where he focused on the mining and tax sectors.

The Company also announces that Abbey Abdiye, Chief Financial Officer of the Company, has resigned to pursue other opportunities. The resignation is effective immediately. The Company would like to thank Mr. Abdiye for his hard work and dedication and wish him well in his future endeavors.

About Loop Insights :

  • Loop Insights Inc. is a Vancouver-based Internet of Things (“IoT”) technology company that delivers transformative artificial intelligence (“AI”) automated marketing, contact tracing, and contactless solutions to the brick-and-mortar space. Its unique IoT device, Fobi, enables data connectivity across online and on-premise platforms to provide real-time, detailed insights and automated, personalized engagement. Its ability to integrate seamlessly into existing infrastructure, and customize campaigns according to each vertical, creates a highly scalable solution for its prospective global clients that span industries. Loop Insights operates in the telecom, casino gaming, sports and entertainment, hospitality, and retail industries, in Canada, the US, the UK, Latin America, Australia, Japan, and Indonesia. Loop’s products and services are backed by Amazon’s Partner Network and sold through the TELUS IoT Marketplace.

    For more information, please contact:
 Loop Insights Inc.LOOP Website : www.loopinsights.ai
 Rob Anson, CEOFacebook: @ LoopInsights
 T : +1 877-754-5336 Ext. 4Twitter: @ LoopInsights
 E : [email protected]LinkedIn: @ LoopInsights

Forward-Looking Statements/Information:  

This news release contains certain statements which constitute forward-looking statements or information. Such forward-looking statements are subject to numerous risks and uncertainties, some of which are beyond Loop’s control, including the impact of general economic conditions, industry conditions, and competition from other industry participants, stock market volatility and the ability to access sufficient capital from internal and external sources. Although Loop believes that the expectations in its forward-looking statements are reasonable, they are based on factors and assumptions concerning future events which may prove to be inaccurate. Those factors and assumptions are based upon currently available information. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors that could influence actual results or events and cause actual results or events to differ materially from those stated, anticipated or implied in the forward-looking statements. As such, readers are cautioned not to place undue reliance on the forward-looking statements, as no assurance can be provided as to future results, levels of activity or achievements. The forward-looking statements contained in this news release are made as of the date of this news release and, except as required by applicable law, Loop does not undertake any obligation to publicly update or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise. The forward-looking statements contained in this document are expressly qualified by this cautionary statement. Trading in the securities of Loop should be considered highly speculative. There can be no assurance that Loop will be able to achieve all or any of its proposed objectives.  

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

CLIENT FEATURE: Fabled Silver Gold Corp. $FCO.ca 3.2Moz Indicated and 1.1Moz Inferred at Santa Maria, Mexico $GGD.ca $EDR.ca $RDU.ca $KTN.ca

Posted by AGORACOM at 4:32 PM on Monday, December 14th, 2020

Fabled Silver Gold Corp. (TSXV: FCO)The Santa María Property is an under-explored, high-grade silver-gold project with significant exploration potential to expand mineral resources and identify new discoveries.

Fabled Silver Gold Company Highlights:

  • Commenced drilling on 100% option at Santa Maria Mine in Mexico 
  • 2020 NI 43-101 Resource of 3.2Moz Indicated and 1.1Moz Inferred in two primary veins
  • Two distinct Epithermal veins have been partially explored
  • Santa María Property is an under-explored, high-grade silver-gold project with significant exploration potential
    • 19 significant vein structures exists within the property and provides future virgin exploration opportunities
    • Drill Hole SM18-03 – Intersected 11.2m of 1,672 g/t Silver & 3.74g/t Gold
      • Hole ended in mineralization
  • Geophysical survey on the property and has successfully identified multiple targets for exploration and drilling

Santa Maria Deposit

High Grade silver-gold property located in mining friendly jurisdiction of Parrall, Mexico

  • The Parral mining district is situated in the center of the Mexican Silver belt, a district of epithermal silver gold mineralization
  • The belt has been recognized as producing more silver than any other equivalent are in the world 
  • 2018 PEA very supportive at current market prices 
  • 2 Mettalurgical Studies completed 
  • Santa Maria vein structures provide many promising exploration and possibly future mining possibilities 
  • The Santa Maria mine has never been systematically, or explored thoroughly with modern methods

The Asset: Santa Maria Mine 43-101

  • 3.2Moz Indicated and 1.1Moz Inferred in two primary veins
  1. High grade silver-gold property located in the mining friendly jurisdiction of Parrall, Chihuahua, Mexico.
  2. The Parral mining district is situated in the centre of the Mexican silver belt epithermal silver-gold vein districts. The belt has been recognized as a significant metallogenic province, which has reportedly produced more silver than any other equivalent area in the world.
  3. 43-101 Technical Report completed on December 02, 2020 by Mineral Resources Engineering.
  4. Significant vein structures within the property provides future exploration and mining opportunities.

Hub On AGORACOM / Corporate Profile

Fabled Silver Gold is an advertising client of AGORA Internet Relations Corp.

VIDEO – Mountain Valley MD $MVMD.ca Catches Small Cap Fire After #Ivermectin Testimony In US Senate Called “Miraculous Effectiveness” In Prohibiting Transmission Of #COVID-19

Posted by AGORACOM-JC at 4:19 PM on Monday, December 14th, 2020

“It basically obliterates transmission of this virus”  

This was the testimony of  Pierre Kory, M.D., Associate Professor of Medicine at St. Luke’s Aurora Medical Center, delivers passionate testimony during the Senate Homeland Security and Governmental Affairs Committee hearing on “Early Outpatient Treatment: An Essential Part of a COVID-19 Solution, Part II.”

We interviewed Leigh Hughes, newly appointed Advisor to MVMD who will be supporting the Company in the areas of M&A, corporate finance and pharmaceutical licensing, to provide us with further insight as to why the testimony of Dr. Kory is so relevant to MVMD … and why Dr. Kory actually called MVMD last week to discuss the Company’s involvement with Ivermectin.

Mountain Valley MD has traded over 50,000,000 shares in the last 3 trading days, so there is a clear need for information amongst retail investors.

CLIENT FEATURE: Else Nutrition $BABY.ca $BABYF Backed By A $2.7 Billion Dollar Global Nutrition Powerhouse $BYND $VERY.ca $INGR $VEGN $TOFB

Posted by AGORACOM-JC at 12:09 PM on Monday, December 14th, 2020
http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png

Else Nutrition Holdings Inc. (BABY: TSXV) (BABYF: OTCQX) (0YF: FSE) is the award winning, plant-based nutrition company for small cap investors. The shift towards plant-based alternatives has opened the food market to new players, and created an opportunity for fast growth in a rapidly expanding space.  Else has fully grasped at this opportunity as seen below.

Highlights include:

  • $CAD 30 Million In Cash
  • Launched 1st Commercial Product Into US Market
  • Backed By A $2.7 Billion Dollar Global Nutrition Company;
  • MOU For International Distribution Of Products
  • “Best Health” Award At Global Food Innovation Summit In Milan;
  • Awarded Patents In 22 Countries, 44 Countries Pending;
  • Executives & Advisors From Globally Renowned Companies & Institutions
  • Distribution agreement with one of the largest and most well regarded national fresh, organic and specialty food distributors in North America
  • Received key Clean Label Certifications for Toddler Nutrition Product
  • Received Key USDA Organic Certification

Else Nutrition’s Complete Nutrition for Toddlers ranked Top-Selling Product on Amazon’s Hot New Releases in Baby and Toddler Formula Category 

Hub On AGORACOM / Corporate Profile

Else Nutrition Holdings is an advertising client of AGORA Internet Relations Corp.